×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: CBS Single-Cell Transcriptomics Mechanisms
mechanism
1,481 words
KG: CBS Single-Cell Transcriptomics Mechanisms
2026-04-01
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
CBS Single-Cell Transcriptomics Mechanisms
⚙
Mechanism Info
Name
CBS Single-Cell Transcriptomics Mechanisms
Summary
Page for CBS Single-Cell Transcriptomics Mechanisms
Knowledge Graph
Related Hypotheses (30)
Membrane Cholesterol Gradient Modulators
Score: 0.52
SASP-Mediated Complement Cascade Amplification
Score: 0.70
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Microbial Inflammasome Priming Prevention
Score: 0.58
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Complement C1q Mimetic Decoy Therapy
Score: 0.48
Microglial Purinergic Reprogramming
Score: 0.48
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50
Aquaporin-4 Polarization Rescue
Score: 0.51
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Complement C1q Subtype Switching
Score: 0.44
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.38
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53
Senescence-Associated Myelin Lipid Remodeling
Score: 0.51
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.45
Glial Glycocalyx Remodeling Therapy
Score: 0.41
Microglia-Derived Extracellular Vesicle Engineering for Targ
Score: 0.37
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.41
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Show 25 more
Related Experiments (30)
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Single-cell RNA sequencing analysis of human atherosclerotic
exploratory · proposed · Score: 0.90
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
Sex differences in CB1R-mediated cannabinoid analgesia in ne
validation · proposed · Score: 0.90
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Electrophysiological analysis of mPFC-vlPAG synaptic transmi
exploratory · proposed · Score: 0.85
CB1R expression mapping in mPFC-vlPAG circuit
exploratory · proposed · Score: 0.85
s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice
falsification · proposed · Score: 0.40
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40
s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40
Experiment: Autoimmune Hypothesis Testing in AD
clinical · proposed · Score: 0.40
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic
validation · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.40
NPH Glymphatic System Interaction Experiment
clinical · proposed · Score: 0.40
Prion Strain Diversity and Selective Vulnerability
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.40
Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
Show 25 more
See Also (15)
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 3 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 3 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 3 hypotheses
Sex Differences in Neurodegeneration
mechanism · Pages share 3 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 3 hypotheses
Retinal Degeneration Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Microglial Priming Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 3 hypotheses
IL-1 Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
HMGB1 Signaling in Neurodegeneration
mechanism · Pages share 3 hypotheses
gp130/IL-6 Family Cytokine Signaling in Neurodegenerati
mechanism · Pages share 3 hypotheses
Galectin-3 Mechanism in Neurodegeneration
mechanism · Pages share 3 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Dystrophic Neurites in Neurodegeneration
mechanism · Pages share 3 hypotheses
Down Syndrome Neurodegeneration Pathway
mechanism · Pages share 3 hypotheses
Show 10 more